Unc Lineberger Comprehensive Cancer Center
Clinical trials sponsored by Unc Lineberger Comprehensive Cancer Center, explained in plain language.
-
Promising lymphoma combo trial cut short after enrolling just 5 patients
Disease control TerminatedThis study tested a new mix of cancer drugs (PV-RGDP) for people with diffuse large B-cell lymphoma that came back or didn't get better after first treatment. The goal was to see if adding polatuzumab vedotin to standard chemo could improve response. Only 5 people took part befor…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Promising cancer imaging study halted due to funding shortage
Diagnosis TerminatedThis study aimed to see if a new type of ultrasound, called acoustic angiography, could better detect breast and thyroid cancers compared to standard ultrasound. The plan was to scan 45 people, including healthy volunteers and patients scheduled for biopsies. However, the study w…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 13:50 UTC
-
High-tech scan study for prostate cancer radiation fizzles out
Knowledge-focused TerminatedThis study tested whether combining two types of advanced scans (PSMA-PET and MRI) could help doctors better target radiation for men with unfavorable-risk prostate cancer. Only 8 people took part before the study was stopped early. The main goal was to see if this approach was s…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC